
Cognitive symptoms affect between 85% and 94% of patients with major depressive disorder. Despite this prevalence, cognitive dysfunction often remains undertreated and inadequately addressed in routine clinical practice.
Dr Murphy is an associate professor in the Department of Psychiatry at the University of Oxford. Murphy has received consultancy fees from Zogenix, Sumitomo Dainippon Pharma, UCB Pharma, and Janssen Pharmaceuticals. She holds grant income from UCB Pharma, Janssen Pharmaceuticals, and ADM.
Cognitive symptoms affect between 85% and 94% of patients with major depressive disorder. Despite this prevalence, cognitive dysfunction often remains undertreated and inadequately addressed in routine clinical practice.
Published: March 24th 2025 | Updated: